Basic Materials / Specialty ChemicalsNYSE
$77.49
+0.83 (+1.08%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $28.3M · quality 35.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
37/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.1B
P/E
N/A
•EV/EBITDA
N/A
•ROE
N/A
•Gross Margin
29.5%
↑Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2010–2025 · 15 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
+7.6%
FCF margin
9.8%
FCF / Net income
0.88x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $485.6M · net income $54.0M · FCF $47.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||
| Revenue | $485.6M | $485.6M | $437.6M | $413.0M | $348.6M | $305.0M | $283.2M | $277.0M | $266.0M | — | — | — | — | — | — | — | — |
| Net Income | $54.0M | $54.0M | $39.4M | $29.6M | $5.7M | $11.1M | $18.9M | $12.6M | $8.2M | $10.8M | $13.6M | $11.4M | $8.4M | $14.6M | $6.1M | $9.1M | $9.5M |
| EBITDA | $90.3M | $90.3M | $70.7M | $51.7M | $20.4M | $28.3M | $38.8M | $23.7M | $28.6M | $28.0M | $27.6M | $27.1M | $22.8M | $27.8M | $19.4M | $22.2M | $20.9M |
| EPS | — | — | 2.72 | 2.07 | 0.41 | — | — | 0.83 | 0.56 | 0.73 | 0.94 | 0.80 | 0.58 | 1.03 | 0.42 | 0.63 | 0.65 |
| Gross Margin | 29.5% | 29.5% | 28.6% | 25.0% | 17.9% | 21.4% | 24.3% | 23.7% | 27.0% | — | — | — | — | — | — | — | — |
| Operating Margin | 14.0% | 14.0% | 11.8% | 9.9% | 3.0% | 4.3% | 8.8% | 3.8% | 6.0% | — | — | — | — | — | — | — | — |
| Net Margin | 11.1% | 11.1% | 9.0% | 7.2% | 1.6% | 3.6% | 6.7% | 4.6% | 3.1% | — | — | — | — | — | — | — | — |
| Balance Sheet | |||||||||||||||||
| Debt/Equity | — | — | 0.34 | 0.24 | 0.30 | 0.12 | — | — | — | — | — | — | — | — | — | — | — |
| Current Ratio | — | — | 3.45 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | |||||||||||||||||
| Free Cash Flow | $47.6M | $47.6M | $28.3M | $25.4M | $-13.0M | $-5.2M | $27.7M | $11.7M | $-4.5M | $12.2M | $14.5M | $11.1M | $-2.3M | $13.6M | $16.4M | $-698000.00 | $15.8M |
| Returns | |||||||||||||||||
| ROE | — | — | 18.7% | 16.7% | 3.8% | 7.0% | — | — | — | 8.6% | 11.8% | 10.3% | 8.0% | 14.2% | 7.1% | — | — |
| Valuation | |||||||||||||||||
| P/E | — | — | 21.41 | 15.39 | 34.01 | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | — | — | 20.03 | 10.99 | 10.92 | 9.04 | — | — | — | — | — | — | — | — | — | — | — |
| P/B | — | — | 6.50 | 3.14 | 1.29 | 1.64 | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | |||||||||||||||||
| Revenue Growth | 11.0% | 11.0% | 5.9% | 18.5% | 14.3% | — | 2.2% | 4.1% | — | — | — | — | — | — | — | — | — |
| EPS Growth | — | — | 31.4% | 411.1% | — | — | — | 50.5% | -24.5% | -21.4% | 17.6% | 35.9% | -43.5% | 143.5% | -32.5% | -3.1% | — |
| Dividend Yield | — | — | 1.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+54.5%
Start / end P/E
n/dx → n/dx
EPS bridge
2.72 → n/d
Residual
+54.5%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.